Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,747 total articles
Amazon looks set for a valuation re-rate as AWS benefits from AI infrastructure spending and retail efficiencies gradually improve. This trade idea outlines an actionable long with a clear entry, stop and target across a 45-trading-day horizon.
Tower Semiconductor's foundry push into silicon photonics is moving from R&D to pre-production and early commercialization. With partnerships and product announcements in February and institutional buying into capacity expansion, the stock looks ripe for a tactical long to capture initial revenue upside and re-rating. This trade targets the market'…
ATI (ATI) makes the special metals that modern aircraft and defense platforms need. With aerospace production recovering, high-value alloy demand rising, and limited global capacity for nickel/titanium products, ATI looks well positioned. We lay out a position-sized, risk-defined trade for a long entry at $144, stop at $128 and target of $165 over …
Nvidia is priced for growth but still has room to run into GTC 2026 if management delivers credible roadmaps for agentic AI and a new LPU product family. The trade is a mid-term tactical long with clear entry, stop and target, sized for disciplined risk-taking around the conference catalyst.
Enphase has been punished for inventory and guidance noise, but the business fundamentals - positive free cash flow, a $6.3B enterprise value, and improving technical posture - argue for a tactical long. This trade plan targets a measured rally toward prior highs while protecting capital against headline risk and litigation noise.
SoundHound AI sells core voice, sound and conversational AI to automotive, restaurant and enterprise customers. Revenue nearly doubled to $169M in 2025 and management guided $225M-$260M for 2026, but the stock has plunged from its 2025 highs and sits at a rich multiple that looks punchable on a trade. This idea lays out an actionable long trade: en…
Nvidia's fundamentals remain rock-solid: massive market cap, exceptional free cash flow and a high ROE. With technicals neutral and short interest elevated, an upcoming 'Nebius' catalyst could trigger a rapid repricing. This trade targets a mid-term move over the next 45 trading days with defined risk controls.
CI&T is showing signs of durable revenue growth driven by its AI-enabled Flow platform and an expanding North American footprint. At a market cap of roughly $722M and a forward-leaning strategy, the risk/reward for a long trade looks attractive if you respect a disciplined stop and the company continues to convert pipeline into bookings.
Atlassian still posts meaningful cash generation and keeps growing its enterprise footprint, but GAAP profitability has lagged. The stock trades at roughly 15x free cash flow and under $20B market cap — attractive for a company with durable products if management can convert revenue growth into margin expansion. This trade targets a rebound as AI t…
Brazil Potash (GRO) looks attractively priced for a long-term construction / pre-production re-rate. Market cap $182M, secured offtake for ~91% of planned volumes and a 10-year take-or-pay for ~900k tpa position the Autazes project as a meaningful domestic supply alternative. Trade plan: enter at $3.42, stop $2.70, target $6.00 on confirmation of 2…
Microsoft (MSFT) is a core long with resilient fundamentals and strong free cash flow. Use a mid-term (45 trading days) swing trade: entry $402.90, target $460.00, stop $372.00. Valuation looks reasonable for a market-cap leader: P/E ~25, EV/EBITDA ~17, free cash flow $77.4B, ROE 30.5% and low leverage. Catalysts include AI infrastructure spending …
Sandisk ($633.50) has been volatile after a breakout year but the fundamental drivers that pushed the stock higher - hyperscaler AI spending, tight NAND supply and improving data-center contracts - remain intact. The company has positive free cash flow, limited net debt and a still-deep float; that combination supports a tactical buy with a mid-ter…
Sutro Biopharma (STRO) is trading near its 52-week high after a financing and early-stage ADC progress. The trade idea is a cautious long: entry $24.50, target $32.00, stop $18.00, horizon 180 trading days. The thesis rests on momentum into multiple ADC programs and cleaner balance-sheet runway; the counterpoint is steep clinical and cash-flow risk…
Broadcom is winning AI infrastructure design wins and reported strong top-line and margin expansion, yet its valuation and exposure to hyperscaler capex cycles create a clear trade-off. We lay out a mid-term trade: buy on weakness near $339, target $380, stop $312, and explain the catalysts and risks that could make or break the trade over the next…
Oracle’s recent results show explosive AI infrastructure growth inside a cash flow-challenged capital structure. With cloud infrastructure up 84% and AI infrastructure revenue up 243% in the latest quarter, the company looks positioned to capture outsized demand for data-center capacity. This trade targets a measured long position that leans on con…
Microsoft is trading below key moving averages after a broad market risk-off. Fundamentals remain strong: $2.98T market cap, $77.4B free cash flow, 30% return on equity and a conservative balance sheet. This trade targets a recovery driven by AI infrastructure spending, steady cloud growth and buyback support. Entry $400.00, target $460.00, stop $3…
Stereotaxis builds robotic magnetic navigation systems for cardiac procedures. At a $175M market cap and an enterprise value near $165M, the stock offers asymmetric upside into an expanding magnetic ablation and medical robotics market, but negative EPS, recurring free-cash-flow deficits and tight liquidity make this a high-risk, high-reward swing …
Zoom Communications plunged after a softer-than-expected quarter and a cautious 2027 outlook. The pullback creates a risk-adjusted entry: the company sits on $7.8B of cash and generates roughly $1.8B in annual free cash flow, trading near 13x adjusted earnings. This trade idea targets a recovery/re-rating over the next 180 trading days while protec…
Microsoft is trading off on macro and AI spending headlines, but its cash generation, margins, and modest leverage make the sell-off an overreaction. This is a mid-term swing trade: buy near current levels, target a recovery toward the $450 area, and use a tight stop under $380 to limit downside if the market keeps punishing capex narratives.
Nano Labs has moved from pure-play fabless chips toward cryptocurrency reserves and Web3 initiatives while the CEO has bought 480,000 shares. The market cap is $69.5M and the shares trade near their 52-week low at $2.95. Technical indicators show fading momentum but a bullish MACD histogram; short interest and short-volume are elevated. This trade …
Renault's recent Strategy Day delivered clearer product cadence, cost-out targets and capital allocation priorities that, if executed, should lift margins and re-rate the stock. Financial detail was limited in the materials reviewed, but the strategic priorities and potential catalysts justify a mid-term long trade with disciplined stops.
Meta Platforms ($META) is trading below its recent trend and looks like the most attractively priced member of the large-cap AI/tech cohort. With a $1.61T market cap, free cash flow of $46.1B and a trailing P/E around 27, the company offers durable ad revenue growth from its Family of Apps and heavy leverage to the AI infrastructure buildout via Re…
Mosaic (MOS) is a leveraged, cash-generative fertilizer producer that just picked up a strategic optionality with a rare-earths project in Brazil. Near-term fertilizer market tightening and limited Chinese exports set a bullish backdrop; the Uberaba partnership adds a multi-year upside that could justify a re-rating. Trade setup: enter $31.90, stop…
Aquestive collapsed after an FDA letter flagged deficiencies in the Anaphylm NDA. The market priced in a painful outcome; the balance sheet and upcoming investor events give a path to rehypothecated upside if management can show a credible fix or timeline. This is a speculative, mid-term swing trade with asymmetric upside vs. controlled downside.
Berkshire Hathaway offers a defensive equity play in a market shaped by geopolitical shocks and elevated commodity volatility. With a $1.06T market capitalization, $373.3B of cash reported at year-end 2025, and a conservative balance sheet, the company is positioned to buy assets, return capital, or buffer underwriting losses. We recommend a long p…
